Children with ITP before MMR had no vaccine associated recurrences.doi:10.1136/adc.84.3.227MilleraImmunisation Division, Public Health Laboratory Service Communicable Disease Surveillance Centre, Colindale, London NW9 5EQ, UK, bDepartment of Statistics, The Open University, Milton Keynes MK7 6AA, UK...
The MMR triple vaccine provides protection from measles, mumps and rubella (German measles). These diseases can have serious complications such as convulsions, temporary or permanent deafness, meningitis, brain damage and even death. However, since the introduction of the MMR vaccine in 1988, these...
The court had ruled 13 months ago that a combination of the measles-mumps-rubella vaccine, commonly known as the MMR vaccine, and thimerosal does not cause the disorder, so the new ruling may finally close the bulk of litigation on the matter. The earlier ruling has been appealed to the U...
At the time of the MMR controversy, some parents paid privately to have separate, single doses of the MMR vaccine in the belief that this would minimise potential risks. Reference to media reporting of a death in Conventry, UK, which was later reported to be unrelated to the HPV vaccine....
Postponing vaccination indefinitely means that the TD subjects will not have adequate vaccine cover and this will expose them to the risk of contracting the wild-type virus, presenting serious complications, leading to an additional transfusion burden and worsening of the TD patient’s clinical conditi...
(N= 11) attitudes about the measles, mumps, and rubella vaccine (MMR) in general and about advancing MMR1 administration. Overly positive parent attitudes were contrasted by members of a vaccine-skeptical organization including parents considering that their child was seriously vaccine-injured long ...
There is a final clinical trial, NCT05269381, that explores the safety and tolerability of a personalized neoantigen peptide-based vaccine combined with pembrolizumab in patients with advanced solid tumors (See Table 4 for additional information). Table 4. Summary of all currently on-going clinical ...